Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 14/10/19941 min de lecture
National Institute of Mental Health; Licensing Opportunity and/or Opportunity for a Cooperative Research and Development Agreement (CRADA) for the Use of Retroviral Vectors With Gibbon Ape Leukemia Virus (GaLV) Components
Traduction automatique locale · Langue originale de la source
Résumé
The National Institutes of Health is seeking licensees and/or CRADA partners for the further development, evaluation, and commercialization of novel retroviral vectors with Gibbon Ape Leukemia Virus (GaLV) components. The invention claimed in the following patent application is available for either exclusive or non-exclusive licensing (in accordance with 35 U.S.C. 207 and 37 CFR Part 404) and/or further development under a CRADA for important clinical and research applications as described below in the Supplementary Information:
Langue originale de la source: Federal Register — Health and Human ServicesOuvrir le communiqué original →